Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis

References

• World Health Organization. WHO expert consultation on rabies. Second report. World Health Organ Tech Rep Ser.2013; 1–139. back cover.
   Web of Science ®Google Scholar
• Hampson K, Coudeville L, Lembo T, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9:e0003709.
   PubMed Web of Science ®Google Scholar
• Hampson K, Dobson A, Kaare M, et al. Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Dis. 2008;2:e339.
   PubMed Web of Science ®Google Scholar
• Hampson K, Dushoff J, Cleaveland S, et al. Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol. 2009;7:0462.
   Web of Science ®Google Scholar
• World Health Organization. Rabies vaccines: WHO position paper. Weekly epidemiological record 2018 [cited 2018 Apr]. Available from: http://apps.who.int/iris/bitstream/handle/10665/272371/WER9316.pdf?ua=1
   Google Scholar
• World Health Organization. Rabies vaccine: WHO position paper. Wkly Epidemiol Rec. 2010;32:309–320.
   Google Scholar
• Ravish HS, Vijayashankar V, Madhusudana SN, et al. Safety and immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis. Hum Vaccin Immunother. 2014;10:2433–2437.
   PubMed Web of Science ®Google Scholar
• Ambrozaitis A, Laiskonis A, Balciuniene L, et al. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Vaccine. 2006;24:4116–4121.
   PubMed Web of Science ®Google Scholar
• Briggs DJ, Banzhoff A, Nicolay U, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ. 2000;78:693–698.
   PubMed Web of Science ®Google Scholar
• Quiambao BP, Dimaano EM, Ambas C, et al. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine. 2005;23:1709–1714.
   PubMed Web of Science ®Google Scholar
• Warrell MJ, Riddell A, Yu LM, et al. A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl Trop Dis. 2008;2:e224.
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Mani RS. Intradermal vaccination for rabies prophylaxis: conceptualization, evolution, present status and future. Expert Rev Vaccines. 2014;13:641–655.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO position paper on rabies vaccine. Grading of scientific evidence. 2010 [updated 2010 Aug 6. Cited 2017 Jun 7]. Available from: http://wwwwhoint/immunization/rabies_grad_efficacypdf?ua=1
   Google Scholar
• Sudarshan MK, Mahendra BJ, Madhusudana SN, et al. Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis. Hum Vacci. 2005;1:187–190.
   PubMed Web of Science ®Google Scholar
• Giesen A, Gniel D, Malerczyk C. 30 years of rabies vaccination with Rabipur: a summary of clinical data and global experience. Expert Rev Vaccines. 2015;14:351–367.
   PubMed Web of Science ®Google Scholar
• Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. Jama. 2015;313:1657–1665.
   PubMed Web of Science ®Google Scholar
• Scottish Intercollegiate Guidelines Network. Critical appraisal: notes and checklists. 2015. Available from: http://www.sign.ac.uk/methodology/checklists.html
   Google Scholar
• Deeks J, Higgins J, Altman D. Chapter 9: analysing data and undertaking meta-analysis. In: Higgins JPT GSe, editor. Cochrane handbook for systematic reviews of interventions. Version 5.0.1. London: The Cochrane Collaboration; Updated Sep 2008.
   Google Scholar
• Sehgal S, Bhattacharya D, Bhardwaj M. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population. J Commun Dis. 1995;27:36–43.
   PubMedGoogle Scholar
• Ashwathnarayana DH, Madhusudana SN, Sampath G, et al. A comparative study on the safety and immunogenicity of purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purified Vero cell rabies vaccine (PVRV, Verorab). Vaccine. 2009;28:148–151.
   PubMed Web of Science ®Google Scholar
• Charanasri U, Meesomboon V, Kingnate D, et al. Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine. J Med Assoc Thai. 1992;75:639–643.
   PubMedGoogle Scholar
• Chhabra M, Ichhpujani RL, Bhardwaj M, et al. Safety and immunogenicity of the intradermal Thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine. Indian J Med Microbiol. 2005;23:24–28.
   PubMedGoogle Scholar
• Deshpande AK, Londhe VA, Akarte S, et al. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine. J Assoc Physicians India. 2003;51:655–658.
   PubMedGoogle Scholar
• Khawplod P, Tantawichien T, Wilde H, et al. Use of rabies vaccines after reconstitution and storage. Clin Infect Dis. 2002;34:404–406.
   PubMed Web of Science ®Google Scholar
• Li R, Li Y, Wen S, et al. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study. Hum Vaccin Immunother. 2015;11:435–442.
   PubMed Web of Science ®Google Scholar
• Liu H, Huang G, Tang Q, et al. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Hum Vacci. 2011;7:220–224.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang H, Li J, et al. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Hum Vaccin Immunother. 2014;10:2805–2812.
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Anand NP, Shamsundar R. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies. Natl Med J India. 2001;14:145–147.
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Sanjay TV, Mahendra BJ, et al. Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. Hum Vacci. 2006;2:200–204.
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Sanjay TV, Mahendra BJ, et al. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Int J Infect Dis. 2004;8:175–179.
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Tripathi KK. Post exposure studies with human diploid cell rabies vaccine and purified chick embryo cell vaccine: comparative serological responses in man. Zentralbl Bakteriol. 1989;271:345–350.
   PubMedGoogle Scholar
• Miranda EA, Lacuesta TLV, Suquila JT, et al. Safety and immunogenicity of purified Vero cell rabies vaccine versus purified chick embryo cell rabies vaccine using pre-exposure and post exposure regimen among healthy volunteers in San Lazaro Hospital. Philippine J Intern Med. 2014;52:1–7.
   Google Scholar
• Narayana A, Manoharan A, Narayan MS, et al. Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases. Hum Vaccin Immunother. 2015;11:1748–1753.
   PubMed Web of Science ®Google Scholar
• Natarajan M, Mukundan P, John TJ. Immune response to purified chick embryo cell culture rabies vaccine manufactured in India. Indian J Med Res. 1992;95:51–53.
   PubMed Web of Science ®Google Scholar
• Salva EP, Dimaano EM, Villarama JBR, et al. An evaluation of the safety and potency of equine rabies immunoglobulin through measurement of suppression on vaccine-induced antibody production among healthy volunteers. Philippine J Intern Med. 2014;52:1–7.
   Google Scholar
• Sudarshan MK, Madhusudana SN, Mahendra BJ, et al. Evaluation of a new five-injection, two-site, intradermal schedule for purified chick embryo cell rabies vaccine: a randomized, open-label, active-controlled trial in healthy adult volunteers in India. Curr Ther Res Clin Exp. 2005;66:323–334.
   PubMed Web of Science ®Google Scholar
• Sudarshan MK, Narayana DH, Madhusudana SN, et al. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India. Hum Vaccin Immunother. 2012;8:1077–1081.
   PubMed Web of Science ®Google Scholar
• Suntharasamai P, Chaiprasithikul P, Wasi C, et al. A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis. Vaccine. 1994;12:508–512.
   PubMed Web of Science ®Google Scholar
• Suntharasamai P, Warrell MJ, Viravan C, et al. Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis. Epidemiol Infect. 1987;99:755–765.
   PubMed Web of Science ®Google Scholar
• Venkataswamy MM, Madhusudana SN, Sanyal SS, et al. Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes. Clin Exp Vaccine Res. 2015;4:68–74.
   PubMed Web of Science ®Google Scholar
• Beran J, Honegr K, Banzhoff A, et al. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine. Vaccine. 2005;23:3902–3907.
   PubMed Web of Science ®Google Scholar
• Bijok U, Barth R, Gruschkau H, et al. Clinical trials in healthy volunteers with the new purified chick embryo cell rabies vaccine for man. J Commun Dis. 1984;16:61–69.
   PubMedGoogle Scholar
• Lalosevic D, Lalosevic V, Lazarevic-Ivanc L, et al. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans. Dev Biol (Basel). 2008;131:421–429.
   PubMedGoogle Scholar
• Mahendra BJ, Narayana DA, Agarkhedkar S, et al. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen). Hum Vaccin Immunother. 2015;11:428–434.
   PubMed Web of Science ®Google Scholar
• Scheiermann N, Baer J, Hilfenhaus J, et al. Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man. Zentralbl Bakteriol Mikrobiol Hyg A. 1987;265:439–450.
   PubMedGoogle Scholar
• Vodopija I, Baklaic Z, Vodopija R. Rabipur: a reliable vaccine for rabies protection. Vaccine. 1999;17:1739–1741.
   PubMed Web of Science ®Google Scholar
• Vodopija I, Sureau P, Smerdel S, et al. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vaccine. 1988;6:283–286.
   PubMed Web of Science ®Google Scholar
• Hu Q, Liu MQ, Zhu ZG, et al. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hum Vaccin Immunother. 2014;10:1645–1649.
   PubMed Web of Science ®Google Scholar
• Huang G, Liu H, Cao Q, et al. Safety of post-exposure rabies prophylaxis during pregnancy: a follow-up study from Guangzhou, China. Hum Vaccin Immunother. 2013;9:177–183.
   PubMed Web of Science ®Google Scholar
• Kamoltham T, Khawplod P, Wilde H. Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine. Vaccine. 2002;20:3272–3276.
   PubMed Web of Science ®Google Scholar
• Kamoltham T, Singhsa J, Promsaranee U, et al. Elimination of human rabies in a canine endemic province in Thailand: five-year programme. Bull World Health Organ. 2003;81:375–381.
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Anand NP. Response to purified chick embryo cell rabies vaccine administered intradermally for post-exposure prophylaxis. Natl Med J India. 1997;10:115–116.
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Anand NP, Shamsundar R. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals. Int J Infect Dis. 2002;6:210–214.
   PubMedGoogle Scholar
• Sampath G, Parikh S, Sangram P, et al. Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals. Vaccine. 2005;23:1102–1105.
   PubMed Web of Science ®Google Scholar
• Sehgal S, Bhardwaj M, Bhatia R. Clinical evaluation of purified chick embryo cell antirabies vaccine for post-exposure treatment. J Commun Dis. 1988;20:293–300.
   PubMedGoogle Scholar
• Sehgal S, Bhardwaj M, Bhattacharya D. Immunogenicity and feasibility of purified chick embryo cell vaccine. Indian Pediatr. 1994;31:133–137.
   PubMedGoogle Scholar
• Selvakumar R, John TJ. Immune response to purified chick embryo cell culture rabies vaccine (Rabipur) in dog-bite victims. Indian J Med Res. 1989;89:217–220.
   PubMed Web of Science ®Google Scholar
• Sirikwin S, Likanonsakul S, Waradejwinyoo S, et al. Antibody response to an eight-site intradermal rabies vaccination in patients infected with human immunodeficiency virus. Vaccine. 2009;27:4350–4354.
   PubMed Web of Science ®Google Scholar
• Tanphaichitra D, Siristonpun Y. Study of the efficacy of a purified chick embryo cell vaccine in patients bitten by rabid animals. Intern Med. 1987;02:163–1658.
   Google Scholar
• Tanterdtham S, Chaiprasithikul P, Yuthavong K, et al. Follow-up of protective antibody level after post-exposure vaccination with purified tissue culture rabies vaccine (PCEC) small doses intradermally. J Med Assoc Thai. 1991;74:498–501.
   PubMedGoogle Scholar
• Wasi C, Chaiprasithikul P, Auewarakul P, et al. The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment. Southeast Asian J Trop Med Public Health. 1993;24:461–466.
   PubMedGoogle Scholar
• Briggs DJ, Dreesen DW, Nicolay U, et al. Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine. 2000;19:1055–1060.
   PubMed Web of Science ®Google Scholar
• Deshpande A, Briggs D, Branzhoff A Investigation of immune responses to purified chick embryo cell tissue culture rabies vaccine (PCECV) in HIV infected individuals using a simulated post-exposure regimen. Proceedings of XIII International AIDS conference Durban, 2000 Jul 9–14; South Africa.
   Google Scholar
• Salomao C, Nacima A, Cuamba L, et al. Epidemiology, clinical features and risk factors for human rabies and animal bites during an outbreak of rabies in Maputo and Matola cities, Mozambique, 2014: implications for public health interventions for rabies control. PLoS Negl Trop Dis. 2017;11:e0005787.
   PubMed Web of Science ®Google Scholar
• Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention–United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports 2008; 57:1–28.
   Google Scholar
• Veerararghavan N. Phenolized vaccine treatment of people exposed to rabies in Southern India. Bull World Health Organ. 1954;10:789–796.
   PubMedGoogle Scholar
• Cornwall J. Statistics of anti-rabic inoculations in India. Br Med J. 1923;2(3268):298.
   Google Scholar
• Sitthi-Amorn C, Jiratanavattana V, Keoyoo J, et al. The diagnostic properties of laboratory tests for rabies. Int J Epidemiol. 1987;16:602–605.
   PubMed Web of Science ®Google Scholar
• Tenzin, Dhand NK, Gyeltshen T, et al. Dog bites in humans and estimating human rabies mortality in rabies endemic areas of Bhutan. PLoS Negl Trop Dis. 2011;5:e1391.
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports 2010; 59:1–9.
   Google Scholar
• Saesow N, Chaiwatanarat T, Mitmoonpitak C, et al. Diffusion and fate of intramuscularly injected human rabies immune globulin. Acta Trop. 2000;76:289–292.
   PubMed Web of Science ®Google Scholar
• Louie RE, Dobkin MB, Meyer P, et al. Measurement of rabies antibody: comparison of the mouse neutralization test (MNT) with the rapid fluorescent focus inhibition test (RFFIT). J Biol Stand. 1975;3:365–373.
   PubMedGoogle Scholar
• Lavan RP, King AI, Sutton DJ, et al. Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings. Vaccine. 2017;35:1668–1674.
   PubMed Web of Science ®Google Scholar
• World Health Organization and World Organisation for Animal Health. Global elimination of dog-mediated human rabies. Report of the rabies global conference. [ updated 1995 Dec 10–11; cited 2018 Apr]. Available From: http://apps.who.int/iris/bitstream/handle/10665/204621/WHO_HTM_NTD_NZD_2016.02_eng.pdf;jsessionid=519FC33AD28731BAAB4215B8006DC8D3?sequence=1
   Google Scholar
• World Health Organization. Rabies: guide for post-exposure prophylaxis. [ Cited 2017 Jun 7]. Available from: http://wwwwhoint/rabies/human/postexp/en/
   Google Scholar
• Centers for Disease Control and Prevention. Rabies, Medical care. [ Cited 2015 Dec 17]. Available from: http://www.cdc.gov/rabies/medical_care/index.html
   Google Scholar
• Davlin S, Lapiz SM, Miranda ME, et al. Factors associated with dog rabies vaccination in Bhol, Philippines: results of a cross-sectional cluster survey conducted following the island-wide rabies elimination campaign. Zoonoses Public Health. 2013;60:494–503.
   PubMed Web of Science ®Google Scholar
• Davlin SL, Lapiz SM, Miranda ME, et al. Knowledge, attitudes, and practices regarding rabies in Filipinos following implementation of the Bohol Rabies Prevention and Elimination Programme. Epidemiol Infect. 2014;142:1476–1485.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Gavi’s learning agenda drives change for rabies. [ Cited 2018 Apr]. Available from: http://wwwwhoint/rabies/news/Gavis_learning_agenda_drives_change_for_rabies/en/
   Google Scholar